News
Article
Author(s):
Catch up on coverage from the second day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.
To stay informed with the latest conference insights, subscribe to receive our eNewsletters.
Janelle Ball of BC Educators offers actionable tips to boost prior authorization success and improve patient support in dermatology practices.
Apremilast improved joint symptoms and quality of life in patients with early oligoarticular PsA, with consistent efficacy across all BMI categories.
Adam Friedman, MD, FAAD, breaks down how to differentiate chronic hand eczema from similar conditions using history, morphology, and key clinical clues.
A poster at SDPA highlights that dermatologists play a vital role in early detection of metastatic breast cancer, with skin changes often serving as the initial clue of internal disease recurrence.
Orit Markowitz, MD, shares how her color wheel method boosts diagnostic clarity in dermoscopy by simplifying how clinicians assess benign lesions.
Adam Friedman, MD, FAAD, outlines a stepwise approach to treating chronic hand eczema, from vehicle selection to systemic therapies and future innovations.
Subcutaneous spesolimab maintained durable GPP control for 12 months after rapid clearance from IV spesolimab in a high-risk elderly patient.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.